help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rivellese, A. A.
Right arrow Articles by Annuzzi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rivellese, A. A.
Right arrow Articles by Annuzzi, G.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2153-2159
Copyright © 2004 by The Endocrine Society

Exogenous and Endogenous Postprandial Lipid Abnormalities in Type 2 Diabetic Patients with Optimal Blood Glucose Control and Optimal Fasting Triglyceride Levels

Angela A. Rivellese, Claudia De Natale, Lucrezia Di Marino, Lidia Patti, Ciro Iovine, Silvana Coppola, Stefano Del Prato, Gabriele Riccardi and Giovanni Annuzzi

Department of Clinical and Experimental Medicine (A.A.R., C.D.N., L.D.M., L.P., C.I., S.C., G.R., G.A.), Federico II University, 80131 Naples, Italy; and Department of Endocrinology and Metabolism, University of Pisa (S.D.P.), 56124 Pisa, Italy

Address all correspondence and requests for reprints to: Dr. Angela A. Rivellese, Department of Clinical and Experimental Medicine, Medical School, Federico II University, Via S. Pansini 5, 80131 Naples, Italy. E-mail: rivelles{at}unina.it.

The aim of this study was to evaluate exogenous and endogenous lipoprotein responses to a standard fat-rich meal in type 2 diabetic patients with optimal fasting triglyceridemia and optimal blood glucose control. Seven type 2 diabetic patients and five nondiabetic controls (age, 49 ± 7 and 48 ± 4 yr; body mass index, 28.3 ± 3.6 and 25.1 ± 3.6 kg/m2; mean ± SD) were given, after at least 12 h of fasting, a standard fat-rich meal. Before and over the 6 h after the meal, serial blood samples were taken for determination of glucose, insulin, lipids, lipoproteins, apolipoprotein B-48 (apo B-48), apo B-100, free fatty acids, and lipoprotein lipase activity. The main abnormality in the postprandial lipid response of diabetic patients involved large very low density lipoproteins. In these particles, apo B-48, apo B-100, cholesterol, and triglyceride incremental areas were, in fact, significantly higher in diabetics compared with controls [7.08 ± 2.65 vs. 1.17 ± 0.88 mg/liter·h, 65.5 ± 11.5 vs. 12.4 ± 1.77 mg/liter·h, 29.7 ± 3.9 vs. 13.1 ± 3.1 mg/dl·h (0.77 ± 0.10 vs. 0.34 ± 0.08 mmol/liter·h), 170 ± 31 vs. 94 ± 22 mg/dl·h (1.93 ± 0.35 vs. 1.06 ± 0.25 mmol/liter·h)] (all P < 0.05; mean ± SEM). Postprandial preheparin lipoprotein lipase plasma activity was, if anything, higher in diabetic patients. In conclusion, even with fasting normotriglyceridemia and optimal blood glucose control, type 2 diabetic patients are characterized, in the postprandial period, by a significant increase in large very low density lipoproteins of both endogenous and exogenous origins.

This work was supported by a grant from the Ministry of Health (ICS 110.1/RF 98.97).

Abbreviations: apo, Apolipoprotein; FFA, free fatty acid; HDL, high-density lipoprotein; HL, hepatic lipase; IDL, intermediate-density lipoprotein; LDL, low-density lipoprotein; LPL, lipoprotein lipase; Sf, Svedberg flotation unit; VLDL, very LDL.




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
S. S Lund, L. Tarnow, M. Frandsen, U. M Smidt, O. Pedersen, H.-H. Parving, and A. A Vaag
Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes
Eur. J. Endocrinol., January 1, 2008; 158(1): 35 - 46.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Shah, B. Adams-Huet, L. Brinkley, S. M. Grundy, and A. Garg
Lipid, Glycemic, and Insulin Responses to Meals Rich in Saturated, cis-Monounsaturated, and Polyunsaturated (n-3 and n-6) Fatty Acids in Subjects With Type 2 Diabetes
Diabetes Care, December 1, 2007; 30(12): 2993 - 2998.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
W. L. Isley, J. M. Miles, B. W. Patterson, and W. S. Harris
The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus
J. Lipid Res., January 1, 2006; 47(1): 193 - 200.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. Annuzzi, C. De Natale, C. Iovine, L. Patti, L. Di Marino, S. Coppola, S. Del Prato, G. Riccardi, and A. A. Rivellese
Insulin Resistance Is Independently Associated With Postprandial Alterations of Triglyceride-Rich Lipoproteins in Type 2 Diabetes Mellitus
Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2397 - 2402.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society